Bardakci, M. Et Al. 2023. Comparison of the efficacy and safety of 3 months of CAPOX followed by 3 months of capecitabine and 6 months of CAPOX/FOLFOX in the adjuvant treatment of low-risk stage-III colon cancer treated surgically.. Oncology .

Bardakci, M., Demirtas Esmer, D., Hafizoglu, E., Yaslikaya, Ş., Genc, T. B., Ozcelik, M., ... Erdat, E. C.(2023). Comparison of the efficacy and safety of 3 months of CAPOX followed by 3 months of capecitabine and 6 months of CAPOX/FOLFOX in the adjuvant treatment of low-risk stage-III colon cancer treated surgically.. Oncology .

Bardakci, Murat Et Al. "Comparison of the efficacy and safety of 3 months of CAPOX followed by 3 months of capecitabine and 6 months of CAPOX/FOLFOX in the adjuvant treatment of low-risk stage-III colon cancer treated surgically.," Oncology , 2023

Bardakci, Murat Et Al. "Comparison of the efficacy and safety of 3 months of CAPOX followed by 3 months of capecitabine and 6 months of CAPOX/FOLFOX in the adjuvant treatment of low-risk stage-III colon cancer treated surgically.." Oncology , 2023

Bardakci, M. Et Al. (2023) . "Comparison of the efficacy and safety of 3 months of CAPOX followed by 3 months of capecitabine and 6 months of CAPOX/FOLFOX in the adjuvant treatment of low-risk stage-III colon cancer treated surgically.." Oncology .

@article{article, author={Murat Bardakci Et Al. }, title={Comparison of the efficacy and safety of 3 months of CAPOX followed by 3 months of capecitabine and 6 months of CAPOX/FOLFOX in the adjuvant treatment of low-risk stage-III colon cancer treated surgically.}, journal={Oncology}, year=2023}